Washington, DC Weight Loss Surgeons Discuss New Link Between Obesity Surgery and Diabetes Treatment

WASHINGTON, DC--(Marketwire - May 16, 2012) - Thanks to two recent studies published in The New England Journal of Medicine, researchers and surgeons have established a tangible link between bariatric surgery and the treatment of type 2 diabetes. Doctors with the Bluepoint Surgical Group, a team of bariatric surgeons in Northern, VA and Washington, DC, say the new findings suggest weight loss procedures are the most effective therapies for type 2 diabetes in obese and morbidly obese patients and should be considered sooner and more often by patients battling with the disease. The Bluepoint Surgical Group says it is encouraged by the results of these trials and hopes they help patients find the most successful treatments for type 2 diabetes on their return to a healthier life.

As the first head-to-head studies to compare bariatric surgery versus medical therapy, The New England Journal of Medicine reports that bariatric surgery procedures such as gastric banding or gastric sleeve have proven to be superior to medical treatment such as pharmaceuticals in producing the remission of type 2 diabetes. One study, conducted by the Cleveland Clinic, shows within one year type 2 diabetes remission rates with bariatric surgery were 40%, compared to 12% for patients treated with the best pharmacotherapy available. A similar two-year study from the Catholic University of Rome, Italy and New York-Presbyterian/Weill Cornell Medical Center experienced remission rates of about 85% for bariatric surgery (75% gastric bypass, 95% biliopancreatic diversion) and zero for medical therapy in patients with BMI greater than 35. Dr. Amir Moazzez and Dr. Denis Halmi of the Bluepoint Surgical Group say they have seen similar results from their patients who have undergone surgical treatment through weight loss surgery in Washington, DC.

Dr. Halmi and the rest of the Bluepoint Surgical Group say the implications of the two studies will have enormous effects on the future of diabetes treatment. While weight loss surgery procedures have always been known to produce significant results in life expectancy (89% improvement according to the latest study from the American Society for Metabolic and Bariatric Surgery), he says patients are also able to reduce the risk of more serious health complications such as heart disease, stroke, hypertension, and now diabetes, a correlation he is eager to explore both at his practice and through further research.

"Research like this helps patients make informed decisions about bariatric surgery. The article here adds credence to the fact that the surgery does more for the patient than just aid in weight loss, if often times reduces other life-threatening conditions the patient may have," says Dr. Halmi.

Because of the gravity of the decision to undergo weight loss surgery, the Bluepoint Surgical Group strongly urges patients to consult with a board-certified and experienced bariatric surgeon before deciding on a procedure, whether it be a gastric bypass or revisional bariatric surgery. Dr. Halmi says through partnership with a dedicated and knowledgeable practice, patients can make a serious difference in their lives. Now equipped with further evidence pointing towards the benefits of bariatric procedures, he adds that he is excited about the future of weight loss surgery and hopes to continue pursuing the highest quality care for his patients in eliminating both type 2 diabetes and obesity.

About Denis J. Halmi, MD, FACS

Dr. Denis Halmi completed his surgical residency at the Brooklyn Hospital Center in New York. Board-certified in general surgery, he has completed over 1,500 gastric bypass surgeries and over 100 laparoscopic gastric bands. Dr. Halmi is the Medical Director of the Weight Loss Surgery Center at Potomac Hospital and a designated Center of Excellence Surgeon by the American Society for Metabolic and Bariatric Surgery.

About the Bluepoint Surgical Group

As a Designated Center of Excellence by the American Society of Bariatric Surgeons, the Bluepoint Surgical Group is comprised of a team of bariatric, general, and laparoscopic surgeons focusing on a range of procedures including colon/rectal surgery, weight loss procedures, and several plastic surgery options. Doctors with the practice have performed over 2000 weight loss operations and also offer long term weight management assistance programs through dietary education, nutritional counseling, and support groups.

The Bluepoint Surgical Group has three locations in the Washington, DC area: 3620 Joseph Siewick Drive Suite 200 in Fairfax, VA, reachable at (703) 620-3211; 2280 Opitz Blvd Suite 320 in Woodbridge, VA, reachable at (703) 878-7610; and 125 Hospital Center Blvd Suite 207 in Stafford, VA, reachable at (540) 318-6135. It can also be contacted online via the website bluepointgroup.com or the Bluepoint Surgical Group Facebook page.